Knopp RH - Search Results

1

Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

Singh S, Willig JH, Mugavero MJ, Crane PK, Harrington RD, Knopp RH, Kosel BW, Saag MS, Kitahata MM, Crane HM. Singh S, et al. Among authors: knopp rh. Clin Infect Dis. 2011 Feb 1;52(3):387-95. doi: 10.1093/cid/ciq111. Epub 2010 Dec 28. Clin Infect Dis. 2011. PMID: 21189273 Free PMC article.

2

Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?

Knopp RH, Paramsothy P. Knopp RH, et al. Nat Clin Pract Endocrinol Metab. 2006 Mar;2(3):136-7. doi: 10.1038/ncpendmet0116. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932272 Clinical Trial. No abstract available.

3

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).

Knopp RH, d'Emden M, Smilde JG, Pocock SJ. Knopp RH, et al. Diabetes Care. 2006 Jul;29(7):1478-85. doi: 10.2337/dc05-2415. Diabetes Care. 2006. PMID: 16801565 Clinical Trial.

4

Combined statin and niacin therapy remodels the high-density lipoprotein proteome.

Green PS, Vaisar T, Pennathur S, Kulstad JJ, Moore AB, Marcovina S, Brunzell J, Knopp RH, Zhao XQ, Heinecke JW. Green PS, et al. Among authors: knopp rh. Circulation. 2008 Sep 16;118(12):1259-67. doi: 10.1161/CIRCULATIONAHA.108.770669. Epub 2008 Sep 2. Circulation. 2008. PMID: 18765395 Free PMC article.

5

Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.

Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D. Knopp RH, et al. Am J Med. 1994 Jun 6;96(6A):69S-78S. doi: 10.1016/0002-9343(94)90235-6. Am J Med. 1994. PMID: 8017470 Clinical Trial.

6

Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia: preliminary report.

Knopp RH, Frolich JJ. Knopp RH, et al. Am J Cardiol. 1994 May 26;73(14):39D-41D. doi: 10.1016/0002-9149(94)90631-9. Am J Cardiol. 1994. PMID: 8198023 Clinical Trial.

7

Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.

Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH. Broyles FE, et al. Among authors: knopp rh. Am J Cardiol. 1995 Jul 13;76(2):129A-135A. doi: 10.1016/s0002-9149(05)80035-9. Am J Cardiol. 1995. PMID: 7604788 Clinical Trial.

8

Management of patients with diabetic hyperlipidemia.

Knopp RH, Retzlaff B, Aikawa K, Kahn SE. Knopp RH, et al. Am J Cardiol. 2003 Apr 3;91(7A):24E-28E. doi: 10.1016/s0002-9149(02)03385-4. Am J Cardiol. 2003. PMID: 12679200 Review.

9

Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk.

Knopp RH, Paramsothy P, Atkinson B, Dowdy A. Knopp RH, et al. Am J Cardiol. 2008 Apr 17;101(8A):48B-57B. doi: 10.1016/j.amjcard.2008.02.038. Am J Cardiol. 2008. PMID: 18375242 Review.

10

Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease.

Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, Zhao XQ, Albers JJ, Knopp RH. Brown BG, et al. Among authors: knopp rh. Am J Cardiol. 1997 Jul 15;80(2):111-5. doi: 10.1016/s0002-9149(97)00303-2. Am J Cardiol. 1997. PMID: 9230143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page